Orthobiologics Market - Global Forecast to 2022
Orthobiologics Market by Product (Viscosupplementation, Synthetic Orthobiologics, DBM, BMP, PRP, BMAC, Allograft), Application (Fracture Recovery, Osteoarthritis, Spinal Fusion, Soft Tissue), End User (Hospitals, ASCs, Academia)
(EMAILWIRE.COM, March 13, 2019 ) The global orthobiologics market is projected to reach USD 6.06 Billion by 2022 from USD 4.66 Billion in 2017, at a CAGR of 5.4% during the forecast period. Factors such as rising burden of orthopedic injuries; increasing incidence of sports injuries and road accidents; increasing incidence of spinal fusion surgeries; risk factors associated with increasing aging population, obesity rate, & high incidence of musculoskeletal disorders; and growing patient preference for minimally invasive procedures are driving the market.
Download PDF Brochure : https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=162747970
Orthobiologics Market Stakeholders
-Orthobiologics Product Manufacturing Companies
-Product Suppliers, Distributors, and Channel Partners
-Hospitals and Ambulatory Care Centers
-Orthopedic and Dental Clinics
-Research Laboratories and CROs
-Research and Academic Institutes
-National and International Regulatory Authorities
-Government and Non-government Organizations
-Market Research Firms
On the basis of end user, the market is segmented hospitals, orthopedic clinics, and ambulatory care centers; research & academic institutes; and dental clinics and facilities. The hospitals, orthopedic clinics, and ambulatory care centers segment is poised to grow at the fastest rate during the forecast period. This can be attributed to the growing geriatric population (coupled with the increasing number of spinal fusion surgeries performed); road accident injuries and bone fractures; growing prevalence of spinal disorders; and growing awareness of products.
The report covers the orthobiologics market across four major geographies, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America is expected to command the largest share of the market in 2017 due to the increasing incidence of spinal disorders, rising geriatric and obese population, growing preference for minimally invasive procedures, and growing physician and patient awareness about newly introduced treatment procedures and technologies.
Request Sample Pages : https://www.marketsandmarkets.com/requestsampleNew.asp?id=162747970
Some of the major players operating in this market are Medtronic, DePuy Synthes, and Zimmer Biomet. The other players in this market include Bioventus, Arthrex, Harvest Technologies, Globus Medical, Orthofix International, and RTI Surgical.
Media Contact
- Mr. Shelly Singh
- sales@marketsandmarkets.com